CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Total Assets Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual total assets in 2023 was 1.66 Billion CNY , up 1.44% from previous year.
CStone Pharmaceuticals's latest quarterly total assets in 2024 Q1 was 1.53 Billion CNY , down -7.82% from previous quarter.
CStone Pharmaceuticals reported annual total assets of 1.63 Billion CNY in 2022, down -27.87% from previous year.
CStone Pharmaceuticals reported annual total assets of 2.27 Billion CNY in 2021, down -39.63% from previous year.
CStone Pharmaceuticals reported quarterly total assets of 1.53 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
CStone Pharmaceuticals reported quarterly total assets of 1.65 Billion CNY for 2023 Q1, up 1.3% from previous quarter.

Annual Total Assets Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Total Assets of CStone Pharmaceuticals (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	1.66 Billion CNY	1.44%
2022	1.63 Billion CNY	-27.87%
2021	2.27 Billion CNY	-39.63%
2020	3.76 Billion CNY	27.52%
2019	2.95 Billion CNY	80.79%
2018	1.63 Billion CNY	189.24%
2017	564.28 Million CNY	-31.7%
2016	826.13 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	1.53 Billion CNY	-7.82%
2024 Q2	1.53 Billion CNY	0.0%
2023 Q1	1.65 Billion CNY	1.3%
2023 Q3	1.66 Billion CNY	0.14%
2023 Q2	1.65 Billion CNY	0.0%
2023 FY	1.66 Billion CNY	1.44%
2023 Q4	1.66 Billion CNY	0.0%
2022 Q1	2.01 Billion CNY	-11.3%
2022 FY	1.63 Billion CNY	-27.87%
2022 Q4	1.63 Billion CNY	0.0%
2022 Q3	1.63 Billion CNY	-18.68%
2022 Q2	2.01 Billion CNY	0.0%
2021 Q4	2.27 Billion CNY	0.0%
2021 Q3	2.27 Billion CNY	-21.44%
2021 FY	2.27 Billion CNY	-39.63%
2021 Q1	2.89 Billion CNY	-23.16%
2021 Q2	2.89 Billion CNY	0.0%
2020 Q1	2.33 Billion CNY	-20.92%
2020 Q3	3.76 Billion CNY	61.26%
2020 Q2	2.33 Billion CNY	0.0%
2020 FY	3.76 Billion CNY	27.52%
2020 Q4	3.76 Billion CNY	0.0%
2019 Q3	2.95 Billion CNY	-14.28%
2019 FY	2.95 Billion CNY	80.79%
2019 Q4	2.95 Billion CNY	0.0%
2019 Q2	3.44 Billion CNY	0.0%
2019 Q1	3.44 Billion CNY	110.89%
2018 Q4	1.63 Billion CNY	-7.53%
2018 Q1	- CNY	-100.0%
2018 Q3	1.76 Billion CNY	0.0%
2018 FY	1.63 Billion CNY	189.24%
2017 FY	564.28 Million CNY	-31.7%
2017 Q4	564.28 Million CNY	0.0%
2016 FY	826.13 Million CNY	0.0%

Peer Total Assets Comparison of CStone Pharmaceuticals

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-305.374%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	85.223%